Tower Research Capital (TRC)’s Telomir Pharmaceuticals TELO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.8K	Buy	8,646 +5,929	+218%	+$7.41K	﹤0.01%	3934
2025 Q1	$8.78K	Buy	2,717 +362	+15%	+$1.17K	﹤0.01%	3852
2024 Q4	$9.7K	Buy	2,355 +857	+57%	+$3.53K	﹤0.01%	3883
2024 Q3	$9.62K	Buy	1,498 +550	+58%	+$3.53K	﹤0.01%	3852
2024 Q2	$4.56K	Buy	+948	New	+$4.56K	﹤0.01%	4767